Press release from Companies: Double Bond Pharmaceutical avslutar mötet med Key Opinion Leader (KOL), en viktig milstolpe för klinisk studie, fas 1 för SI-053
Press release from Companies: Double Bond Pharmaceutical concludes Key Opinion Leader (KOL) meeting, an important milestone for SI-053 Phase 1 clinical study